Skip to main content

Advertisement

Log in

Recent trends of cervical cancer and Cervical Intraepithelial Neoplasia 3 (CIN3) in Israel

  • Gynecologic Oncology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

This study describes time trends of cervical cancer and Cervical Intraepithelial Neoplasia 3 (CIN3) in Israel in the years 1986–2010 and characterizes these patients by demographics.

Methods

A retrospective survey based on cervical cancer and CIN3 data documented in the computerized system of the second largest Health Maintenance Organizations (HMO) in Israel, “Maccabi Healthcare Services” (MHS) between 1986 and 2010.

Results

737 cervical cancer patients and 3,459 patients of CIN3 were reported between 1986 and 2010. The mean age of women with cervical cancer was significantly higher (mean 49.1 years) than that of CIN3 patients (mean 36.3 years) (p-value < 0.0001). The annual age-adjusted incidence rate of cervical cancer increased significantly from 1.6 per 100,000 in 1986 to 3.7 per 100,000 in 2010 (p for trend = 0.0001) and for CIN3, from 3.9 per 100,000 in 1986 to 40.4 per 100,000 in 2010 (p for trend = 0.0001). For cervical cancer, using the Joinpoint software we demonstrated an increase in the age-adjusted incidence rate between 1986 and 2003 and since then, a decrease was observed. Cervical cancer and CIN3 were mostly common in the Tel Aviv District.

Conclusions

Although quite low to begin with, the incidence rates of cervical cancer and CIN3 in Israel may be further lowered by implementing an organized screening program and introduction of the HPV vaccine into the national immunization program.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Globocan 2012. Cervical cancer incidence and mortality worldwide in 2012 summary. Cancer fact sheet. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx. Accessed 29 Dec 2014

  2. Israeli National Cancer Registry, Israeli Center for Disease Control, Ministry of Health. Annual Reports. http://www.health.gov.il/UNITSOFFICE/HD/ICDC/ICR/CANCERINCIDENCE/Pages/about.aspx. Accessed 01 Jan 2015

  3. Michalas SP (2000) The Pap test: George N. Papanicolaou (1883–1962). A screening test for the prevention of cancer of uterine cervix. Eur J Obstet Gynecol Reprod Biol 90:135–138

    Article  CAS  PubMed  Google Scholar 

  4. Cook GA, Draper GJ (1984) Trends in cervical cancer and carcinoma in situ in Great Britain. Br J Cancer 50:367–375

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Johannesson G, Geirsson G, Day N (1978) The effect of mass screening in Iceland, 1965–1974, on the incidence and mortality of cervical carcinoma. Int J Cancer 21:418–425

    Article  CAS  PubMed  Google Scholar 

  6. Kitchener HC, Castle PE, Cox JT (2006) Achievements and limitations of cervical cytology screening. Vaccine 24(Suppl 3):S3/63–70

  7. Insinga RP, Glass AG, Rush BB (2004) Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynecol 191:105–113

    Article  PubMed  Google Scholar 

  8. Bornstein J, Schejter E (2007) Pap screening in Israel. Ob/Gyn Updat 57:4–6

    Google Scholar 

  9. Schejter E, Bornstein J, Siegler E (2013) Cervical cancer screening, human papillomavirus vaccination practices and current infrastructure in Israel. Vaccine 31(Suppl 8):I42–I45. doi:10.1016/j.vaccine.2012.06.099

    Article  PubMed  Google Scholar 

  10. Bassal R, Rosin LS, Schvimer M, Schejter E, Ozeryansky B, Kulik S, Bachar R, Shapira H, Sandbank J, Cohen D, Keinan-Boker L (2014) Prevalence and correlates of human papillomavirus genotypes among patients with cervical cancer and cervical intraepithelial neoplasia 3 in Israel. J Low Genit Tract Dis (Epub ahead of print)

  11. Crowe E, Pandeya N, Brotherton JM, Dobson AJ, Kisely S, Lambert SB, Whiteman DC (2014) Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case–control study nested within a population based screening programme in Australia. BMJ 348:g1458. doi:10.1136/bmj.g1458

    Article  PubMed Central  PubMed  Google Scholar 

  12. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19

    Article  CAS  PubMed  Google Scholar 

  13. Israeli Social Security. Periodical surveys—Membership in Health Maintenance organizations. https://www.btl.gov.il/Publications/Pages/default.aspx. Accessed 08 Mar 2014

  14. Israel Bureau of Statistics (2006) Characterization and classification of local authorities by the socio-economic level of the population. Table 1, Local Councils and Municipalities - Rank, Cluster Membership, Population, Variable Values, Standardized Values and Ranking for the Variables Used in the Computation of the Index. http://www.cbs.gov.il/publications/local_authorities06/local_authorities_e.htm. Accessed 01 Jan 2015

  15. Joinpoint (2014) Statistical Research and Applications Branch, National Cancer Institute. Joinpoint Regression Program, Version 4.1.1. http://surveillance.cancer.gov/joinpoint. Accessed 14 Sept 2014

  16. Ngelangel C, Muñoz N, Bosch FX, Limson GM, Festin MR, Deacon J, Jacobs MV, Santamaria M, Meijer CJ, Walboomers JM (1998) Causes of cervical cancer in the Philippines: a case–control study. J Natl Cancer Inst 90:43–49

    Article  CAS  PubMed  Google Scholar 

  17. Villa LL (2012) Cervical cancer in Latin America and the Caribbean: the problem and the way to solutions. Cancer Epidemiol Biomarkers Prev. 21:1409–1413. doi:10.1158/1055-9965.EPI-12-0147

    Article  PubMed  Google Scholar 

  18. Cervical cancer: UK incidence statistics. Cancer Research UK. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/cervix/incidence/uk-cervical-cancer-incidence-statistics. Accessed 08 Mar 2014

  19. Kesic V, Poljak M, Rogovskaya S (2012) Cervical cancer burden and prevention activities in Europe. Cancer Epidemiol Biomarkers Prev 21:1423–1433. doi:10.1158/1055-9965.EPI-12-0181

    Article  PubMed  Google Scholar 

  20. National Cancer Institute. SEER Stat Fact Sheets: Cervix Uteri. NCI website. http://www.seer.cancer.gov/statfacts/html/cervix.html. Accessed 01 Dec 2014

  21. Hosono S, Kawase T, Matsuo K, Watanabe M, Kajiyama H, Hirose K, Suzuki T, Kidokoro K, Ito H, Nakanishi T, Yatabe Y, Hamajima N, Kikkawa F, Tajima K, Tanaka H (2010) HLA-A alleles and the risk of cervical squamous cell carcinoma in Japanese women. J Epidemiol 20:295–301

    Article  PubMed Central  PubMed  Google Scholar 

  22. Glezerman M, Piura B, Insler V (1989) Cervical cancer in Jewish women. Am J Obstet Gynecol 161:1186–1190

    Article  CAS  PubMed  Google Scholar 

  23. Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Møller H, Hakama M, Parkin DM (2005) Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 14:677–686

    Article  PubMed  Google Scholar 

  24. Foley G, Alston R, Geraci M, Brabin L, Kitchener H, Birch J (2011) Increasing rates of cervical cancer in young women in England: an analysis of national data 1982–2006. Br J Cancer 105:177–184. doi:10.1038/bjc.2011.196

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Anttila A, Pukkala E, Söderman B, Kallio M, Nieminen P, Hakama M (1999) Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963–1995: recent increase in cervical cancer incidence. Int J Cancer 83:59–65

    Article  CAS  PubMed  Google Scholar 

  26. Mathew A, George PS (2009) Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix—worldwide. Asian Pac J Cancer Prev 10:645–650

    PubMed  Google Scholar 

  27. Mosavi-Jarrahi A, Kliewer EV (2013) Cervical cancer incidence trends in Canada: a 30-year population-based analysis. J Obstet Gynaecol Can 35:620–626

    PubMed  Google Scholar 

  28. Cheung FY, Mang OW, Law SC (2011) A population-based analysis of incidence, mortality, and stage-specific survival of cervical cancer patients in Hong Kong: 1997–2006. Hong Kong Med J 17:89–95

    CAS  PubMed  Google Scholar 

  29. Cecchini S, Ciatto S, Zappa M, Biggeri A (1995) Trends in the prevalence of cervical intraepithelial neoplasia grade 3 in the district of Florence, Italy. Tumori 81:330–333

    CAS  PubMed  Google Scholar 

  30. de Almeida FM, de Oliveira JC, Martins E, Curado MP, de Freitas R Jr, Moreira MA (2013) Monitoring the profile of cervical cancer in a developing city. BMC Public Health 13:563. doi:10.1186/1471-2458-13-563

    Article  PubMed Central  PubMed  Google Scholar 

  31. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX; on behalf of the Retrospective International Survey and HPV Time Trends Study Group (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11:1048–1056. doi:10.1016/S1470-2045(10)70230-8

  32. Giuntoli LR, Bristow RE (2008) Cervical cancer, chapter 58. In: Gibbs RS, Karlan BY, Haney AF, Nygaard IE (eds). Danforth’s Obstetrics and Gynecology, 10th edn. Lippincott Williams and Wilkins, Philadelphia, pp 971–988

  33. Menczer J, Kogan L, Schejter E, Liphshiz I, Barchana M (2011) A population-based study of selected demographic characteristics of Israeli-Jewish women with cervical squamous cell carcinoma. Arch Gynecol Obstet 283:329–333. doi:10.1007/s00404-010-1582-2

    Article  PubMed  Google Scholar 

  34. Kogan L, Menczer J, Shejter E, Liphshitz I, Barchana M (2011) Selected demographic characteristics of Israeli Jewish women with high-grade cervical intraepithelial neoplasia (CIN3): a population-based study. Arch Gynecol Obstet 283:329–333. doi:10.1007/s00404-010-1399-z

    Article  PubMed  Google Scholar 

  35. Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, Ferlay J (2011) Worldwide burden of cervical cancer in 2008. Ann Oncol 22:2675–2686. doi:10.1093/annonc/mdr015

    Article  CAS  PubMed  Google Scholar 

  36. Menczer J, Barchana M, Chetrit A, Liphshitz I, Sadetzki S (2009) Incidence rates of cervical carcinoma among first- and second-generation women of North African origin in Israel. Int J Gynecol Cancer 19:1606–1609. doi:10.1111/IGC.0b013e3181a84035

    Article  PubMed  Google Scholar 

  37. Khan MJ, Partridge EE, Wang SS, Schiffman M (2005) Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer 104:61–70

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to give our sincerest thanks to the following people: Lia Supino Rosin, Michael Schvimer and Judith Sandbank from the Institute of Pathology, Central Lab, Maccabi Healthcare Services, Rehovot, Israel, for their laboratory work.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ravit Bassal.

Additional information

This work was performed in partial fulfillment of the requirements for a Ph.D. degree of Ravit Bassal, Sackler Faculty of Medicine, Tel Aviv University, Israel.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bassal, R., Schejter, E., Bachar, R. et al. Recent trends of cervical cancer and Cervical Intraepithelial Neoplasia 3 (CIN3) in Israel. Arch Gynecol Obstet 292, 405–413 (2015). https://doi.org/10.1007/s00404-015-3655-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-015-3655-8

Keywords

Navigation